Jon Napitupulu

Scilex Holding Company has closed a warrant inducement financing that pulls in approximately $20.3 million in gross proceeds. The...

Bayer has secured FDA accelerated approval for Hyrnuo (sevabertinib), a reversible HER2 tyrosine kinase inhibitor, for adults with locally...

Tarsus Pharmaceuticals will host a fireside chat at the BTIG 5th Annual Ophthalmology Day on December 1, with a...

Nanobiotix has closed a non-dilutive royalty financing with Healthcare Royalty valued up to $71 million, securing $50 million upfront...

Nanobiotix has closed a non-dilutive royalty financing with Healthcare Royalty worth up to $71 million, securing $50 million upfront...

Praxis Precision Medicines will use the American Epilepsy Society meeting in Atlanta on December 5–9, 2025 to unveil new...

Day One Biopharmaceuticals reported three-year outcomes from the pivotal phase 2 FIREFLY-1 trial of tovorafenib (Ojemda) in pediatric low-grade...

Tonix Pharmaceuticals has secured FDA clearance of an investigational new drug application to study TNX-102 SL (cyclobenzaprine HCl sublingual...

Ocular Therapeutix has randomized the first patient in HELIOS-3, the second of two Phase 3 registrational trials evaluating AXPAXLI...

Rakovina Therapeutics unveiled preclinical progress on a new class of CNS‑penetrant, PARP1‑selective inhibitors at the Society for Neuro‑Oncology 2025...